High Times reports Italy’s fentanyl scarcity despite entrenched opioid use and powerful crime networks. We unpack what that evidence means for drug markets—and the cannabis delivery business.

In a unanimous move, Portland will make personal, non-commercial use and sharing of natural psychedelics a low police priority—without legalizing sales or impaired driving.

Psychedelic Alpha flagged a busy “Psychedelics Week” in DC with multiple meetings. Here’s what that activity could signal for policy, access, and the DMV community.

Marijuana Moment reports a Texas Senate candidate’s alcohol-linked cash haul while opposing cannabis reform—plus new research on teen use and clinical science DMVers should track.

Psychedelic Alpha has introduced The Psychedelic News Feed Podcast, creating a new way to follow psychedelics developments. Here’s why DMV readers should care.

A 1960s hoax claimed banana peels could get you high. Here’s what actually happened, what the FDA and researchers found, and why rumor-busting still matters in the DMV.

A little-known 1969 cannabis journal argued the core points the DEA just made on rescheduling—raising new stakes for patients, researchers, and the DMV in 2026.

NORML’s new op-ed challenges The New York Times’ framing of cannabis. Here’s why that media narrative matters for delivery rules, licensing, and consumer safety in the DMV.

From West Virginia to Hawaii, lawmakers are prepping for FDA-approved psilocybin drugs—not legalizing mushrooms. Here’s what’s moving, who’s behind it, and how it could affect DMV residents.

Splashy headlines about psilocybin and LSD often outpace the science. Here’s how to read studies critically—and what that means for DMV drug policy conversations.

A federal health R&D push is exploring ibogaine for opioid use disorder. Here’s what the ARPA-H workshop and ASCENT-IBO call mean for patients and the DMV.

Fresh FBI data show more than half of last year’s cannabis arrests came from just 10 states. Here’s what that pattern means for DMV residents, delivery compliance, and risk planning.

DoubleBlind Mag reports how Lebanon, the UAE, Jordan, and Egypt are shaping psychedelic-assisted care, from ketamine clinics to policy debates and faith-informed practice.

From Indigenous leadership to hard truths about social media, here’s what stood out at Chacruna’s Psychedelic Culture 2026—and why Virginia residents should pay attention.

Psychedelics are surging into the mainstream, but key knowledge holders remain sidelined. Here’s what that means for DC, Maryland, and Virginia readers in 2026.

Psychedelic Alpha reports the FDA held a public hearing on psychedelics. Here’s what that means, what’s unknown, and how DC, Maryland and Virginia should watch the next steps.

Safety, ethics, dosage, vape pens, and the ibogaine combo—what 5‑MeO‑DMT actually demands, and how DMV readers should navigate it without hype.

MKUltra and modern psyops shape how patients judge claims. Here’s how DMV readers can vet medical marijuana delivery, dosing, and safety without falling for propaganda.

MAPS linked with New Jersey’s HoneyProjects to bring education into a dispensary setting—its first retail cannabis partnership in 40 years—and it could reshape how patients learn.

From Bicycle Day to modern art prints, here’s how LSD blotter design latched onto space themes—and why the revival matters for DC, Maryland, and Virginia culture.